Clinical Trial Update: A Study of VCT220 in Participants With Hypertension and Obesity or Overweight [Phase 2]

View source ↗

Summary

Phase 2 study evaluating VCT220 in adults with hypertension, including those who are obese or overweight. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• VCT220

Snippet

Sponsor: Vincentage Pharma Co., Ltd | Conditions: Hypertension | Phase 2 | Status: NOT_YET_RECRUITING